PTSD Clinical Trials Research Announcement
Redapple Research Protocol
I am conducting clinical research with military veterans, police officers, fire fighters and first responders with Post Traumatic Stress Disorder (PTSD). I am actively seeking 60 research participants and their therapists.
The research protocol method is called Senticon Therapy, a new mental imagery treatment. It appears to allow the patient to relieve stressful signs and symptoms of PTSD without the need for medication. It will be explained in greater detail in the section entitled Senticon Therapy later in this PTSD clinical trials research call for participation.
The study will take place over 12 months, in which the subject will be evaluated with the gold standard for PTSD assessment, the Clinician Administered PTSD Scale (CAPS). The subject will then receive the Senticon Therapy research treatment protocol. Two weeks after Senticon Therapy is used, a post-test is done by the research subject’s therapist using the CAPS to gauge level of PTSD severity. The scores will be compared using the SPSS statistical package to look for correlations between the two test sessions. The research participant will then be evaluated by their therapist using CAPS scoring at 3 months, 6 months, and 12 months to evaluate for long term clinical PTSD status.
The PTSD clinical trials study will gather statistical data on the clinical observation that Senticon Therapy can significantly reduce if not put into remission the natural course of PTSD in sufferers.
Patient Information
Inclusion Criteria
- Police Officers or Veterans
- Between the ages of 18 and 65
- In good physical health
- Active or Inactive Duty
- Willing and able to provide informed consent
- Diagnosis of PTSD from combat or civilian trauma by a licensed mental health professional
- Exhibit clinically significant trauma-related symptoms
Exclusion Criteria
- Inability to comply with study procedures or assessments
- Head trauma to include, loss of consciousness or amnesia greater then 24 hours
- High risk for homicide or suicide
- Patients that are doing well on medication; on or seeking disability benefits from the VA or privately
- Suffering from other Axis I Disorders
Information For Professionals
Mental health professionals are encouraged to collaborate in PTSD research at this challenging time in America. Let us work together so it may lead to significant breakthroughs in the war on PTSD.
Since there will be no therapeutic relationship between the subject and researcher, it is imperative that we locate such eager and willing mental health professionals, who are in the best position to evaluate the severity of PTSD for those in treatment.
Please do not hesitate to contact me for further information.
I welcome your inquiries and look forward to your participation.
Senticon Therapy
Senticon-from the Latin sentire (to discern or perceive by the senses and mind, to feel, to think) and the Latin and Greek icon (an image or representation). This new term for mental imagery has the advantage of not limiting this internal representation to visual perception or what one can imagine as a picture in the mind.
Sensory input appears to be encoded into mental imagery if it involves a significant emotional experience which will be stored in memory.
When a person experiences a new life event with a similar emotional perception, the mental image may be decoded, providing a replay of the original life event and original emotions experienced.
What Senticon Therapy appears to do is process the emotional trauma of PTSD.
Initial results show significant clinical improvement using this treatment, from CAPS rated severe PTSD to mild or moderate severity pre and post research intervention, respectively.
60 research participants are needed to complete the study.
Contact Information
Robert M. Roerich, M.D.
Psychiatrist
Research Website: www.senticon.us
Email: roerich @ senticon.us
820 N. 4th Street, Suite 2
Steubenville, OH 43952
Office phone: 740-283-4520 (Answered by Epicenter)
